Assessment of Eculizumab and C5 Levels in PNH Treatment: Molar Ratio of Eculizumab to C5 Level Effectively Predicts Ongoing Dosage Changes in a Cohort of 50 Patients Treated with Eculizumab
伊库利珠单抗
医学
队列
内科学
免疫学
补体系统
抗体
作者
Darren J. Newton,Claire McKinley,Alonso Ricardo,Michelle D. Hoarty,Louise Arnold,Kathryn Riley,Nicola Copeland,Talha Munir,Morag Griffin,Anita Hill,Peter Hillmen
出处
期刊:Blood [American Society of Hematology] 日期:2017-12-07卷期号:130: 3484-3484被引量:2